Kestra Medical Technologies, Ltd. Operating Cash Flow
Kestra Medical Technologies, Ltd. (KMTS) reported Operating Cash Flow of -$32.30 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-09-14
- Kestra Medical Technologies, Ltd. net cash provided by (used in) operating activities for the quarter ending 2026-07-31 was -$32.30M.
- Kestra Medical Technologies, Ltd. net cash provided by (used in) operating activities for the quarter ending 2026-04-30 was -$18.72M.
- Kestra Medical Technologies, Ltd. net cash provided by (used in) operating activities for the quarter ending 2026-01-31 was -$18.37M.
- Kestra Medical Technologies, Ltd. net cash provided by (used in) operating activities for the quarter ending 2025-10-31 was -$18.34M.
- Kestra Medical Technologies, Ltd. net cash provided by (used in) operating activities for fiscal 2026 was -$81.70M.
- Kestra Medical Technologies, Ltd. net cash provided by (used in) operating activities for fiscal 2025 was -$77.61M.
- Kestra Medical Technologies, Ltd. net cash provided by (used in) operating activities for fiscal 2024 was -$72.23M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-07-31 | -$32.30M 10-Q · filed 2026-09-14 | -$51.02M derived: sum of 2 quarters · filed 2026-09-14 | -$69.38M derived: sum of 3 quarters · filed 2026-09-14 | -$87.72M derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | -$18.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | -$37.09M derived: sum of 2 quarters · filed 2026-07-14 | -$55.43M derived: sum of 3 quarters · filed 2026-07-14 | -$81.70M 10-K · filed 2026-07-14 |
| 2026-01-31 | -$18.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | -$36.71M derived: sum of 2 quarters · filed 2026-03-17 | -$62.98M 10-Q · filed 2026-03-17 | -$87.04M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | -$18.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-11 | -$44.62M 10-Q · filed 2025-12-11 | -$68.67M derived: sum of 3 quarters · filed 2026-09-14 | -$86.67M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-07-31 | -$26.27M 10-Q · filed 2026-09-14 | -$50.33M derived: sum of 2 quarters · filed 2026-09-14 | -$68.33M derived: sum of 3 quarters · filed 2026-09-14 | -$86.38M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | -$24.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | -$42.05M derived: sum of 2 quarters · filed 2026-07-14 | -$60.11M derived: sum of 3 quarters · filed 2026-07-14 | -$77.61M 10-K · filed 2026-07-14 |
| 2025-01-31 | -$18.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | -$36.05M derived: sum of 2 quarters · filed 2026-03-17 | -$53.55M 10-Q · filed 2026-03-17 | |
| 2024-10-31 | -$18.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-11 | -$35.55M 10-Q · filed 2025-12-11 | ||
| 2024-07-31 | -$17.50M 10-Q · filed 2025-09-12 | |||
| 2024-04-30 | -$72.23M 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |